Abstract
Urinary tract infections (UTIs) are among the most common bacterial infections worldwide, affecting millions annually and imposing significant healthcare costs. Rising antibiotic resistance among uropathogens coupled with the limitations of culture-based diagnostics and systemic therapies demands innovative approaches. Nanotechnology offers transformative potential, enabling rapid, point of care (POC) detection and targeted antimicrobial interventions that promise to outperform evolving resistance mechanisms.
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2025 Suresh Babu Naidu Krishna, Vasanthrie Naidoo (Author)